"Sinopharm Pharma Tech" was founded in 2008. It is a member enterprise of China National Pharmaceutical Group Corporation (Sinopharm Group), which ranked 1st among global pharmaceutical enterprises.

Sinopharm Pharma Tech is mainly engaged in the international operation of pharmaceutical raw materials, pharmaceutical intermediates, pharmaceutical excipients, Chinese medicinal materials and pharmaceutical preparations. Since its establishment, the company has established close cooperative relations with more than 130 countries and regions around the world. The operation scale of dozens of its products ranks among the top three in domestic exports, making it a highly trusted partner for overseas clients. Leveraging the advantages of Sinopharm International's overseas network and channel resources, the company deeply cultivates the overseas market and helps Chinese pharmaceutical products, industries and services "go global".

Meanwhile, Sinopharm Pharma Tech is committed to building a world-leading pharmaceutical technology platform and implementing the integrated development strategy of science, trade and industry. The company has a R&D center in Tianjin and a professional R&D team, providing domestic and foreign clients with innovative process development services for pharmaceutical synthesis, as well as high-quality pharmaceutical, medical aesthetics and healthcare products. It has obtained a number of authorized invention patents at home and abroad and built independent brands, and is recognized as a "Double-Independent" enterprise by the Beijing Municipal Government.

Taking advantage of Sinopharm Group's strong brand influence and whole-industry-chain advantages, Sinopharm Pharma Tech takes technological innovation and international operation as its dual driving forces, comprehensively lays out the global market, takes multiple measures to promote the transformation of scientific and technological achievements, and strives to become an industry-leading pharmaceutical technology company